|
Volumn 334, Issue 6052, 2011, Pages 29-30
|
Gene therapists celebrate a decade of progress
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 9;
PARVOVIRUS VECTOR;
PREDNISOLONE;
RETROVIRUS VECTOR;
VIRUS VECTOR;
CELL ORGANELLE;
DEVELOPMENTAL BIOLOGY;
FUNCTIONAL MORPHOLOGY;
GENE EXPRESSION;
GENETIC ANALYSIS;
GENOME;
NUCLEIC ACID;
ADENOSINE DEAMINASE DEFICIENCY;
ADRENOLEUKODYSTROPHY;
BETA THALASSEMIA;
CANCER RISK;
CLINICAL TRIAL (TOPIC);
GENE THERAPY;
HEMOPHILIA B;
HUMAN;
IMMUNOGENICITY;
IMMUNOPATHOLOGY;
LEBER CONGENITAL AMAUROSIS;
LEUKEMIA;
ONCOGENE;
PRIORITY JOURNAL;
RISK REDUCTION;
SHORT SURVEY;
SIDE EFFECT;
VIRUS CAPSID;
VIRUS CARCINOGENESIS;
VIRUS INACTIVATION;
WISKOTT ALDRICH SYNDROME;
X LINKED SEVERE COMBINED IMMUNODEFICIENCY;
ADENO ASSOCIATED VIRUS;
GENE VECTOR;
GENETIC DISORDER;
GENETICS;
NOTE;
RARE DISEASE;
CLINICAL TRIALS AS TOPIC;
DEPENDOVIRUS;
FACTOR IX;
GENE THERAPY;
GENETIC DISEASES, INBORN;
GENETIC VECTORS;
HEMOPHILIA B;
HUMANS;
RARE DISEASES;
|
EID: 80053584696
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.334.6052.29 Document Type: Short Survey |
Times cited : (17)
|
References (0)
|